We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
-14.29%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$16.5B
AUM Growth
-$3.93B
Cap. Flow
-$718M
Cap. Flow %
-4.36%
Top 10 Hldgs %
32.53%
Holding
1,265
New
250
Increased
403
Reduced
360
Closed
243

Sector Composition

Rank Sector Weight
1 Financials 27.58%
2 Energy 14.56%
3 Industrials 13.17%
4 Technology 10.16%
5 Materials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRFS
1001
DELISTED
BRF SA
BRFS
$67K ﹤0.01%
26,131
-42,330
-62% -$125K
ILLM
1002
DELISTED
illumin Holdings Inc. Common Shares
ILLM
$65K ﹤0.01%
+27,800
New +$74.9K
ADMA icon
1003
ADMA Biologics
ADMA
$2.1B
$62K ﹤0.01%
+31,452
New +$61.9K
FARM
1004
DELISTED
Farmer Brothers
FARM
$61K ﹤0.01%
13,067
+2,170
+20% +$12.3K
SFE
1005
DELISTED
Safeguard Scientifics, Inc.
SFE
$58K ﹤0.01%
15,631
-5,420
-26% -$22.6K
MFGP
1006
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$50K ﹤0.01%
+14,964
New +$69.3K
FBIO icon
1007
Fortress Biotech
FBIO
$96.3M
$47K ﹤0.01%
3,743
+2,227
+147% +$33K
RYTM icon
1008
Rhythm Pharmaceuticals
RYTM
$8.14B
$47K ﹤0.01%
+11,225
New +$61.4K
LITS
1009
Lite Strategy Inc
LITS
$30.5M
$46K ﹤0.01%
+3,826
New +$41.7K
SMTS
1010
DELISTED
Sierra Metals Inc. Common Stock
SMTS
$43K ﹤0.01%
53,800
-12,000
-18% -$11.4K
CRIS icon
1011
Curis
CRIS
$3.45M
$40K ﹤0.01%
+101
New +$42.1K
DNTH icon
1012
Dianthus Therapeutics
DNTH
$6.19B
$40K ﹤0.01%
+2,076
New +$51.3K
GRTS
1013
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$40K ﹤0.01%
+16,681
New +$43.8K
SUNW
1014
DELISTED
Sunworks, Inc.
SUNW
$37K ﹤0.01%
23,677
-6,741
-22% -$12.9K
BDTX icon
1015
Black Diamond Therapeutics
BDTX
$119M
$30K ﹤0.01%
+12,330
New +$28.7K
MTEM
1016
DELISTED
Molecular Templates, Inc.
MTEM
$24K ﹤0.01%
1,765
+394
+29% +$9.22K
SYRS
1017
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$16K ﹤0.01%
1,647
-12,069
-88% -$113K
SYBX
1018
DELISTED
Synlogic
SYBX
$12K ﹤0.01%
724
-1,171
-62% -$25.3K
BATRK icon
1019
Atlanta Braves Holdings Series B
BATRK
$3.42B
$1K ﹤0.01%
33
ACB
1020
Aurora Cannabis
ACB
$232M
-5,380
Closed -$214K
ADI icon
1021
Analog Devices
ADI
$188B
-24,496
Closed -$4.05M
AEP icon
1022
American Electric Power
AEP
$68.1B
-23,682
Closed -$2.36M
AGEN
1023
Agenus
AGEN
$307M
-1,472
Closed -$71K
AIZ icon
1024
Assurant
AIZ
$13.9B
-4,221
Closed -$768K
ALTO icon
1025
Alto Ingredients
ALTO
$332M
-74,202
Closed -$506K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q2 2022 Portfolio in Review

As of Q2 2022, Connor, Clark & Lunn Investment Management (CC&L) held 1,265 positions worth $16.5B, down 19% from $20.4B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) withdrew a net $718M in Q2 2022, closing 243 positions and reducing 360 holdings. Its most notable exit was Alibaba, an estimated $44.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Connor, Clark & Lunn Investment Management (CC&L) opened a new position in GSK worth $49.3M.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q2 2022 buy was GSK: 905,598 shares worth $49.3M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Canadian National Railway in Q2 2022, an estimated $87M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q2 2022 reduction was Apple, cutting an estimated $159M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Alibaba in Q2 2022, selling an estimated $44.8M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 33% of its $16.5B portfolio in Q2 2022.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 250 new positions and closed 243 in Q2 2022.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 19% quarter-over-quarter to $16.5B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2022, filed 5 Aug 2022.